Inovio slumps 22% on pricing $20M stock offering (INO:NASDAQ)
· seekingalpha.com
Inovio Pharmaceuticals (INO) priced an underwritten public offering expected to raise approximately $20M in gross proceeds.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...